U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07790640) titled 'Evaluate the Efficacy and Safety of CTO0308 in Pediatric Patients With Myopia' on Aug. 24.
Brief Summary: This study was to evaluate the superiority of the myopia progression control effect in the treatment group compared with the control group, evaluated by the change in spherical equivalent (SE) after 12 months of administration of the investigational product.
Study Start Date: Aug. 11, 2025
Study Type: INTERVENTIONAL
Condition:
Myopia
Intervention:
DRUG: CTO0308
Ophthalmic solution, one drop in each eye, once daily
DRUG: Vehicle (Placebo solution)
Vehicle, one drop in each eye, once daily
Recruitment Status: ACTIVE_NOT_...